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= A bs t rac t =High carbohydrate(CH0) diet plays a role in pigment gallstone for- 
mation, though the mechanism is not yet clarified. We postulated that high CHO 
diet induces gallstone formation through a mechanism whereby high CHO diet 
poorly stimulates cholecystokinin(CCK) release and causes relative bile stasis. 
The purpose of our study was t o  examine whether camostat mesilate(camostat), 
oral antiproteinase increasing CCK release, inhibits gallstone formation from 
high CHO diet in hamsters. Fifty six hamsters were divided into 3 groups(G): I(n = 
18)  was fed normal rat chow(43% CHO), II(n = 19)  was fed a high CHO diet(65% 
CHO), III(n = 19)  was fed 0.2% camostat high CHO diet. The animals were sacri- 
ficed after 8 weeks. Stones were checked grossly and gallbladder bile was anal- 
ysed. Gallstones had developed in 11.1% of G-I, 84.2% of G-11, and 26.3% of G- 
III(p < 0.05: 11 vs 111). Concentrations of cholesterol, phospholipid, calcium, biliru- 
bin and bile acid were low in G-111. Pancreatic weight, reflecting chronic status of 
CCK level, of G-I11 was greater than other groups and that of G-I1 was smaller 
than that of G-I. In conclusion, camostat inhibits high CHO diet induced gallstone 
formation in hamsters and the possible mechanism is that camostat recovers the 
low CCK release by high CHO diet. This study suggests that high CHO diet is 
associated with pigment stone formation through the mechanism that high CHO 
diet causes poor CCK release. 
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be related to bile stasis and biliary infection 
INTRODUCTION rather than changes in bile composition. It has 
been suggested that high carbohydrate(CH0) 
The mechanism of pigment gallstone forma- diet plays a role in pigment gallstone formation. 
tion, especially that of calcium bilirubinate Pigment stone is more prevalent in southeast 
stones has not been clearly defined. It seems to Asian countries where the main meal is com- 
posed of a high CHO diet(Park and Kim 1988). 
Epidemiologic studies in Japan have shown that 
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~ j # q .  ?q-++g CHO consumption in food(Nakayama and 
Miyake 1970; Nagase et a1 1978; Nagase et a/ .  
1980). High CHO diet induces pigment gallstone 
formation in hamsters and prairie dogs(Cohen et 
a1.1987; Rege and Nahrwold 1987, Suh et al. 
1993). However. ~t has not been clar~fied how a 
CHO dlet makes gallstones. 
Many investigators have demonstrated how 
gallbladder contractility in response to food 
intake is decreased in patients with gallstone 
disease(Maugda1 et a/ .  1980. Thompson et a/ .  
1982; Fischer et a1 1982; Forgcas el a/ .  1984 
Pomeranz et a/. 1985). Well preserved gallblad- 
der responsiveness to cholecystokinin(CCK) and 
decreased CCK release in response to duodenal 
fat in gallstone d~sease suggest that chronic gall- 
bladder stas~s caused by low CCK release is 
associated with gallstone pathogenesis(Fischer 
et a/ .  1982; Masclee et a/. 1989). 
CCK stimulates gallbladder contraction and 
relaxation of the sphincter of Odd1 It also stimu- 
lates pancreatlc enzyme secretion and pancreat- 
ic growth(Ma1nz et a/ .  1973: Folsch et a/. 1978; 
Solomon et a/ .  1978) CCK release is stimulated 
by intraduodenal digested food material, espe- 
cially protein and fat. CHO is a relat~vely weak 
stimulator compared to proteln and fat(Walsh 
1987). 
CCK release I S  negat~vely controlled by a 
feedback mechanism. Decreasing ~ntraduodenal 
bi le salt by cholestyramine increases CCK 
release and lntraduodenal bile salt decreases 
CCK release(Gomez et a/. 1988). Trypsin lnhlbits 
CCK release and trypsin inhibitor Increases CCK 
release(Brand el a / .  1981 ; Liddle et a / .  1984: 
Yonezawa 1984: Owyang et a/. 1986: Goke et a1 
1986; Watanabe et a/ .  1992). 
Camo~tat (C~,H,~N,0~.CH,S03H).  a syn- 
t h e t ~ c  antiprotease, inh~b i ts  the activities of 
t ryps in ,  p lasmln ,  ka l l ~k re in  and thrombln 
(Muramutu et a / .  1972; Tamura el a / .  1977). 
Camostat is metabolized to Foy-305. a potent 
protease inhibitor. Oral camostat 600 mg blocks 
most of the trypsin activity for 90 minutes in 
humans(Adler et a / .  1988). Trypsin inhibitors 
stimulate pancreatlc secretion and pancreatic 
growth(Goke et a / .  1986; Otsuki et a / .  1987) 
Experimental studies have shown that these 
actions are mediated by CCK(Mainz et a/. 1973; 
Folsch et a / .  1978;  Solomon et a / .  1978;  
Watanabe et al. 1992). Decreased CCK release 
causes pancreatic atrophy and exogenous CCK 
administration reverses this effect(Gomez et a/ .  
1990). Camostat 100 mglkglday increases CCK 
release and induces pancreatic hypertrophy 
(Muramuto et a / .  1972:  Mainz et a / .  1973;  
Solomon et a/ .  1978; Otsuki et a/. 1985; Goke et 
a/ .  1987: Keim et a/ .  1988). 
CHO IS  a weak stimulator for CCK release 
compared to protein and fat. We postulated that 
hlgh CHO diet induces gallstone formation 
through the mechanism that high CHO diet poorly 
st~mulates CCK release and causes relative bile 
stasis. The purpose of our study was to examine 
whether camostat inhlbits gallstone formation from 
high CHO diet in hamsters through the mecha- 
nism of increasing endogenous CCK release. 
MATERIALS AND METHODS 
F~fty SIX male syrlan golden hamsters welgh- 
Ing 98 to 130 gm were used In t h~s  study After a 
1 week accl~mat~zat~on per~od the hamsters were 
dlvlded Into 3 groups Group I (n = 18) was fed 
normal rat chow Group I I  (n = 19) was fed a hlgh 
CHO dlet Group I l l  (n = 19) was fed 0 2% camo- 
stat contalnlng a hlgh CHO dlet D ~ e t  composl- 
tions for each group are shown In Table 1 Slnce 
a hamster fed about 50 gm/kg/day 0 2'6 camo- 
stat diet would be administered camostat 100 
mgikgiday Body we~ght change and amount of 
tood consumption were monitored throughout the 
experlvental period Hamsters were sacr~flced 
after 8 weeks of feedlng after 24 hours fastlng 
They were sacr~ f~ced alternatively w ~ t h ~ n  a short 
per~od of tlme to mlnlmlze d~urnal varation After 
w e ~ g h ~ n g  and anesthetlzlng the hamsters w ~ t h  
ketamlne(  100 m g l k g )  and  d lazepam(0  15 
mg lkg )  the abdomen was wldely opened 
Gallbladder blle was taken w~th an insuln syrlnge 
and stored at 40" C unt~l analyss Presence or 
absence of stone was checked grossly and the 
pancreas and left kldney(as a control) were care- 
fully isolated and wet weights were measured. 
Gallstones were qualitatively analysed by infrared 
spectroscopy (Diffraction grat ing Infrared 
Spectrophotometer, Perkin Elmer FT-IR 
Spectrophotometer 1725). Gallbladder bile was 
analysed using kits. Total bilirubin was measured 
by the method of Michelsson(1981) using T-biliru- 
bin reagents(Kyokut0 Pharm. Japan), calcium 
was measured by the o-cresolphthalein complex- 
on method of Aderegg (1954) using Calcium 
Reagent(Gi1ford Systems, Ohio, USA), phospho- 
lipid was measured by the method using phos- 
pholipase D(Dryer et a/. 1956) (Phospholipase B 
test: Wako, Japan). Cholesterol was measured by 
the method of Roeschlau(1974) using cholesterol 
oxidase(TC-V: Kyokuto Pham., Japan) and total 
bile acid was measured by the method of Turley 
(1977) using 3a hydroxysteroid dehydrogenase 
(Kyokuto Pharm., Japan). 
Chi-square test, Wilkoxon Rank Sum and t- 
test were used for statistical analysis. 
RESULTS 
All the hamsters had been alive and healthy 
withoui diarrhea throughout the experimental 
period. Group Ill appeared to eat less compared 
to the other two groups as shown in the amount 
of diet consumption per body weight (Table 2). 
Group I l l  fa~led to gain weight through the exper- 
imental period (Fig. 1 ) .  Gallstones developed in 
1 1.1 %(2/18) of Group 1 ,  84.2%(16/19) of Group 
I I ,  and 26.3%(5/19) of Group lll(p<0.05: I I  vs I ,  
I l l ) .  High CHO diet increased stone incidence 
Table 1 Compos~tion of 3 types of diet for the 3 groups 
- --- - - -- - - 
Group I(Ol0) Group II(%) Group Ill(%) 
- - --- - - . . --  - 
Carbohydrate 42 6 65 1 64 9 
Corn 29 8 - - 
Wheat 12 8 - - 
R ~ c e  - 58 5 58 3 
Sucrose - G 6 6 6 
Protein 24 2 12 7 12 7 
Fat 6 4 3 1 3 1 
F~ber 4 1 1 1  1 1  
Water 8 9 8 7 8 7 
M~scellaneous 13 8 9 3 9 3 
Camostat - - 0 2 
Group I normal rodent d ~ e t  Group 1 1  h~gh-carboh~~drate d~e t  Group I l l  h~gh-carbohydrate d ~ e t  + camostat 
mes~late 
Table 2 Diet consumpt~on dur~ng the exper~menta period(gmlkg1day) 
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a n d  camosta t  reversed  the ef fect  of th ls 
llthogenlc dlet 
Stones were black-colored and 0 1 to 1 mm 
In slze (Fig 2) Lamellated structure, as seen on 
human calclum blllrub~nate stones, was noted In 
some stones Infrared spectroscopy revealed that 
the major components of these stones were calcl- 
urn phosphate, ca lc~um bll~rublnate cholesterol 
and calc~um palmltate and the pattern was s~mllar 
to human calclum b~l l rub lnate stone (Flg 3)  
Samples from 2 to 3 hamsters( 0 1-0 2 ml from 
each ) were pooled and analysed (Table 3) No 
d~fferences were noted between Group I and 
Group II except for phosphollpld content wh~ch  
was lower In Group Il(p < 0 05) Concentrations 
of all components were qulte low In Group I l l  
compared to the other two groups 
The pancreatlc welght of Group I l l  was 
greater than the other groups and that of Group 
I I  was smaller than that of Group I whereas kid- 
ney welght was slmllar In each group (Table 3) 
Representative sectlons of pancreatlc t~ssues 
from each group are shown In Fig 4 Aclnar size 
a n d  densrty o f  zymogen  granu les  were 
Increased In Group I l l  
DISCUSSION 
Camostat(0.2%) In the d ~ e t  reversed the 
Increased incidence of gallstone from a h ~ g t i  
CHO d ~ e t  in hamsters. S~rlce we have not estab- 
- -  
e 
9 normal rodent diet 
S 
60 high carbohydrate diet 
r high carbohydrate diet 
20 "' t + camostat mesilate 
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w e e k  
Fig 1 Body ;5~e~gtht charnye dur~ny It-ie exper~rner~ i  
Body ~ v e g h t  of Groc~p I l l  hansters vias stationary 
5~I;le the oil ier t ~ v o  groups of  t?ariisters yanecl 
;.,eryht 
Ihshed the CCK assay yet p las~na CCK level 
could not be shown here However it was clearly 
demonstrated ~ r i  this study that a high CHO dlet 
decreased and carrlostat remarkably Increased 
pancreatlc wet we~ght It was evldent In the h ~ s -  
tologic flndlngs as well Camostat stimulates 
pancreatlc growth through the CCK-nied~ated 
mechan~sm(Muramuto el a1 1972 Malnr el a1 
1973 Solomon el a1 1978 Otsukl el dl  1985 
Goke et a1 1986 Rauscti et a1 1987 K e ~ m  et a1 
1988) Pancreatic we~ght In thls study reflected 
the chronic effect of a high CHO dlet and carno- 
stat on  the p lasma CCK level Therefore 
decreased parlcreatic w e ~ g t ~ t  117 Group I I  means 
that high CHO (or o w  prote~n and fat) dlet stlrnu 
late CCK release less arid pmcrea t~c  Iivpertro- 
phy i r l  Group I l l  means that carnostat rriduced 
chron~cally elevated CCK release Ttiese facts 
suggest that relative gallbladder stas~s due to 
weak CCK release by h ~ g h  CHO diet plays a role 
In the k ~ g h  CHO dlet Induced gallstone forma 
t~ori However r i  order to prove this it  I S  essen- 
tial to show that exogenous CCK admin~stration 
also ~ r i h ~ b ~ t s  stone forrndt~ori CCK aiitayonist 
reverses the effect of car-nostat as well as the 
conslstpnt level of plasr-ria CCK 
The dosage  of carnostat In thls s tudy 
Fig. 3. Infrared absorption spectrum of gallstones. The pattern is similar to that of human calcium bilirubinate 
stone. 
Table 3 Gallbladder blle compos~t~on ( Mean ? SE ) 
-- - - -- -- -- . - 
Group I (N = 7) Group II  (N = 8) Group I l l  (N = 8) 
Cholesterol(mg1dl) 111 9 k 8.9 128.7 t 12.3 95.0 k 3.4"** 
Phospholipid(mg1dl) 1682 t 107 1323 t 67* 645 k 55** 
Total Calc~um(mg/dl) 5.3 t 0.4 5.6 k 0.6 4.0 i 0.2"* 
Bilirubin(mg1dl) 28.7 F 2.7 22.3 k 1.6 10.6 i 0.5** 
B~le acid(mmol/L) 100.6 F 6.6 93.3 k 7.9 
- - - -. .- . . -. . -  -. . 
74.3 + 3.4** 
* p-value < 0.05 vs group I ,  * *  p-value < 0.05 vs groups I and l l ,  * * *  p-value < 0.05 vs group ll 
Table 4 Pancreas weight and k~dney we~ght per body weight (Mean + SE) 
Group I 
~ 
pancreas welght(mg1gm) 2 9 - + 0 1 3  
k~dney we~ght (mglgm) 3 9  F 0 0 9  
- -- - - - - 
Group I I  
--  - 
Group Ill 
p-value < 0.05(vs group I ) ,  * *  p-value < 0.001(vs groups I and II) 
appears to be too high. Camostat made the ani- investigate whether camostat induces weight 
mals eat less and fail to gain weight. The authors loss in the adult animals and humans, whether 
believe that it is because increased CCK from diet restriction has any effect on this lithogenic 
camostat stimulates the satiety center in ham- diet model and if low dose camostat still has the 
sters, which is also one of the important actions same effect on gallstone formation without 
of CCK(Gibbs et a/. 1973; Stacher et a/. 1979; change in the diet amount. 
Peikin 1989; Reidelberg et a/. 1989). We need to The infrared spectroscopic pattern of the 
stone was very similar to that of human calcium 
bilirubinate. As it is hard to determine just how 
this stone from hamsters resembles the human 
one, the results of this study can only be a pos- 
tulation. At least we can say that the stones are 
quite different from human cholesterol stones. 
The most important reason for the high propor- 
tion of pigment stones in Asian countries is the 
high proportion of bile duct, especially intrahep- 
atic duct stones in this area. Considering gall- 
bladder stone, the difference between Asian and 
western countries is not so remarkable as 
before. 
Bile composition was not changed principal- 
ly by high CHO diet. Further investigation about 
the significance of the difference in phospholipid 
concentration is needed. In Group I l l  all the 
components measured were remarkably low 
compared to the other groups, in other words, 
camostat diluted gallbladder bile. Since the fast- 
Fig. 4. Microscopic features of pancreas (PAS staining, 
x400).  A :  Group I ,  B: Group I I ,  C :  Group I l l .  
Diameter of acinar glands and the density of 
zymogen granules are much greater in Group I l l  
than those in the other two groups. 
ing duration was very similar in each group and 
hamsters belonging to different groups were 
killed alternatively, no significant physiologic fac- 
tor could be responsible for this phenomenon. 
Malnutrition, (which might be related to less 
feeding) may explain the decreased cholesterol 
concentration, but not the changes in the other 
components. Maintenance of high CCK level by 
camostat increases bile flow and gallbladder 
contractility and, in turn, the gallbladder has not 
enough time for bile concentration. The concen- 
trations of components in Group I l l  may be close 
to those of hepatic bile, though not measured in 
this study. The mechanism of this effect needs to 
be explored. 
Clinical application of antiproteinase has 
been limited to pancreatitis and disseminated 
intravascular coagulation so far, although it has 
not been well established yet. We are now plan- 
ning to try antiproteinase in gallstone disease. 
Antiproteinase may possibly prevent pigment 
stone recurrence after surgery for bile duct 
stones through the mechanism mediated by 
increased CCK release. Biie acid dissolution 
therapy for cholesterol stones has been tried 
with disappointing results. Oral bile acid may 
inhibit CCK release through the feedback mech- 
anism and cause relative bi le stasis. 
Comb~nation with antiproteinase should eliminate 
this possible unfavorable effect of oral bile acid 
therapy and increase the success rate of oral 
dissolution therapy. 
Camostat ~nh~b i t s  high CHO diet induced 
gallstone formation in hamsters. The possible 
mechanism is that camostat recovers the low 
CCK release from the high CHO diet. This study 
suggests that a high CHO diet is associated with 
plgment stone formation through the mechanism 
that high CHO diet causes poor CCK release. 
Antiproteinase is a possible future candidate for 
a prophylactic agent against recurrent pigment 
stones and for a supplementary agent of dissolu- 
tion therapy for cholesterol stones in humans. 
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